TCM
OSIR

Timpani Capital Management’s Osiris Therapeutics, Inc. Common Stock OSIR Stock Holding History

Timpani Capital Management’s Portfolio OSIR Stock Details OSIR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q4 		– Sell
-69,640
Closed -$1.29M – 122
2015
Q3 		$1.29M Buy
+69,640
New +$1.34M 0.52% 80

Other funds holding OSIR

CCM
Consonance Capital Management New York $7.28M AUM 43.59% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
QI
QS Investors New York $8.47B AUM 30.71% 1-Year Est. Return

Timpani Capital Management's OSIR Position: Q4 2015 in Review

Timpani Capital Management sold out of Osiris Therapeutics, Inc. Common Stock (OSIR) in Q4 2015, closing a stake of 69,640 shares — an estimated $1.29M sold.

Timpani Capital Management first reported a position in OSIR in Q3 2015 and held it in 1 quarter. The position peaked at $1.29M in Q3 2015. 81 funds tracked by Wall St. Rank hold OSIR as of Q4 2015.

  • Timpani Capital Management reported no remaining Osiris Therapeutics, Inc. Common Stock position as of Q4 2015 after selling out during the quarter.
  • Timpani Capital Management sold 69,640 Osiris Therapeutics, Inc. Common Stock shares in Q4 2015, an estimated $1.29M.
  • Timpani Capital Management first reported a position in Osiris Therapeutics, Inc. Common Stock in Q3 2015 and held it in 1 quarter.
  • Timpani Capital Management's Osiris Therapeutics, Inc. Common Stock position peaked at $1.29M in Q3 2015.
  • 81 funds tracked by Wall St. Rank held Osiris Therapeutics, Inc. Common Stock as of Q4 2015.

Based on Timpani Capital Management's 13F filing for Q4 2015, filed 4 Feb 2016.